Astrazeneca Pharma India

quarterly
yearly
ParticularsJun '21Sep '21Dec '21Mar '22Jun '22
Revenue175.40197.71200.53231.96232.33
Expenses164.53184.07189.37198.41208.96
EBITDA10.8713.6411.1633.5523.37
EBIT6.119.367.6529.1418.78
Profit Before Tax13.5016.2416.2637.0327.30
Net Profit10.2211.9511.4227.9920.15
Financial Ratios
Operating Profit Margin6.20%6.90%5.57%14.47%10.06%
Net Profit Margin5.83%6.04%5.69%12.07%8.67%
Earning Per Share (Diluted)4.104.704.5711.2111.01
Dividends Per ShareNA2.00NA8.00NA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.3.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI